Mode
Text Size
Log in / Sign up

Wuqinxi exercise reduces systolic and diastolic blood pressure in adults with primary hypertensionWuqinxi Exercise Lowers Blood Pressure in Hypertensive Adults

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider Wuqinxi exercise as a low-cost adjunctive therapy to reduce systolic and diastolic blood pressure.

This meta-analysis evaluated the effects of Wuqinxi exercise on blood pressure and lipid profiles in 770 middle-aged and older adults with primary hypertension. The study assessed outcomes over a follow-up period of 3 to 6 months. The analysis found that Wuqinxi exercise significantly reduced systolic blood pressure (SBP) by 5.3 mmHg and diastolic blood pressure (DBP) by 6.7 mmHg. Additionally, HDL levels increased by 0.71 (95% CI: 0.40 to 1.02) and LDL levels decreased by 0.63 (95% CI: -1.19 to -0.07).

The authors noted that the evidence quality for blood pressure reduction was moderate, while the evidence for HDL and LDL changes was low and very low, respectively. These limitations suggest that the lipid-related findings require confirmation through high-quality randomized controlled trials with standardized protocols.

Clinically, Wuqinxi may serve as a safe, low-cost adjunctive therapy for hypertension. The consistent blood pressure-lowering effects over 3 to 6 months suggest its potential as a non-pharmacological intervention, though the lipid profile improvements remain less certain due to lower evidence quality.

How this fits prior evidence

This finding extends the existing evidence for non-pharmacological hypertension management. While prior coverage noted that combined training reduces 24-hour systolic blood pressure by 6.18 mm Hg, this meta-analysis provides evidence for Wuqinxi exercise reducing systolic blood pressure by 5.3 mmHg and diastolic blood pressure by 6.7 mmHg. It also addresses a gap regarding low-cost adjunctive therapies for blood pressure management.

A new analysis of existing studies suggests that Wuqinxi, a traditional Chinese exercise, may help lower blood pressure in middle-aged and older adults with hypertension. The review combined data from 770 participants across multiple trials, all of whom had primary hypertension. Over a period of 3 to 6 months, those who practiced Wuqinxi saw their systolic blood pressure (the top number) drop by an average of 5.3 mmHg and their diastolic blood pressure (the bottom number) drop by 6.7 mmHg. These effects are modest but could be meaningful for heart health.

The analysis also looked at cholesterol levels. High-density lipoprotein (HDL, or "good" cholesterol) improved, while low-density lipoprotein (LDL, or "bad" cholesterol) decreased. However, the quality of evidence for these lipid changes was low to very low, meaning we can't be as confident in those results. The blood pressure findings were rated as moderate quality.

No safety concerns were reported in the studies, and Wuqinxi is considered a safe, low-cost activity. Still, this was a meta-analysis, not a new experiment, and the studies varied in quality. The lipid benefits, in particular, need confirmation through more rigorous research.

For now, Wuqinxi appears to be a promising addition to standard hypertension care, but it should not replace prescribed medications. If you have high blood pressure, talk to your doctor about whether adding Wuqinxi to your routine could be helpful for you.

What this means for you:
Wuqinxi exercise may help lower blood pressure, but lipid benefits need more research.

Common questions

What is Wuqinxi exercise?

Wuqinxi is a traditional Chinese exercise that involves gentle movements and breathing. It is sometimes called 'Five Animal Frolics' because it mimics movements of animals. It is low-impact and can be done by many people, including older adults.

How much does Wuqinxi lower blood pressure?

In this analysis, people who did Wuqinxi for 3 to 6 months saw their systolic blood pressure drop by about 5.3 mmHg and their diastolic blood pressure drop by about 6.7 mmHg on average. These are modest reductions that could still be beneficial for heart health.

Is Wuqinxi safe for people with high blood pressure?

The studies in this analysis did not report any safety concerns. Wuqinxi is considered a safe, low-cost exercise. However, it's always a good idea to check with your doctor before starting a new exercise routine, especially if you have other health conditions.

Can Wuqinxi replace my blood pressure medication?

No. This analysis suggests Wuqinxi may be a helpful addition to your treatment plan, but it is not a replacement for prescribed medications. Always talk to your doctor before making any changes to your medication or exercise routine.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
PurposeThis study aimed to quantify the therapeutic effects of standardized Wuqinxi exercise on blood pressure, lipid profile, and resting heart rate in middle-aged and older adults with primary hypertension, and to grade the evidence certainty using the GRADE framework.MethodsWe systematically searched Web of Science, Wanfang Data, CNKI, EBSCO, and PubMed (January 2000 to June 30, 2026) for randomized controlled trials (RCTs) evaluating Wuqinxi as an adjunctive intervention for hypertension. Eleven RCTs (770 participants, aged 30–80 years, 3–6 months duration) were included. Primary outcomes were changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), high-density lipoprotein (HDL), and low-density lipoprotein (LDL). Meta-analyses were performed using random-effects models, with pre-specified sensitivity analyses excluding studies with high risk of bias, non-standard protocols, or incompatible controls.ResultsWuqinxi significantly reduced SBP by 5.3 mmHg and DBP by 6.7 mmHg, improved HDL [standardized mean difference (SMD) = 0.71, 95% confidence interval (CI): 0.40–1.02], and reduced LDL (SMD = −0.63, 95% CI: −1.19 to −0.07). GRADE evidence quality was moderate for blood pressure, low for HDL, and very low for LDL.ConclusionWuqinxi is a safe, low-cost adjunctive therapy for hypertension with consistent blood pressure-lowering effects over 3–6 months. We recommend integrating 5–6 sessions weekly into community and clinical hypertension care. Lipid benefits require confirmation through high-quality RCTs with standardized protocols.Systematic review registrationPROSPERO, identifier CRD420261396941.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.